Ovarian cancer
A cancer of the ovaries, the two small organs that store eggs and make female sex hormones. Signs include a swollen or bloated tummy, pain in the tummy or pelvis, feeling full quickly and needing to pee more often. The main treatments are surgery and chemotherapy; targeted medicines may be an option for some people whose cancer is advanced or has come back. It mostly affects women over 50, sometimes runs in families, and is often diagnosed late.
Read more about ovarian cancerTrial-stage treatments and research studies you can join
Filters
- Tests raludotatug deruxtecan, alone or with other drugs, in ovarian cancer
Tests a targeted antibody drug in adults with returned high-grade serous ovarian cancer.
Boston, United StatesAlso Charlottesville, Fort Worth, Houston, Louisville, New Haven, New York, Oklahoma City, Shreveport, …Age 18+ - Tests DT2216 with paclitaxel in ovarian cancer that returned after platinum treatment
Tests DT2216 with paclitaxel in adults with recurrent platinum-resistant ovarian cancer.
Boston, United StatesAge 18+ - Tests M7437 in adults with advanced solid tumors that have Ly6E
Tests the drug M7437 in adults with advanced solid tumors that express Ly6E.
Galveston, United StatesAlso Huntersville, New Haven, San AntonioAge 18+ - ASP546C for stomach, esophagus junction and pancreatic cancer and other solid tumors
Tests ASP546C in adults with advanced gastric, gastroesophageal junction or pancreatic cancer.
Atlanta, United StatesAlso Austin, Basking Ridge, Birmingham, Commack, Detroit, Durham, Fairfax, Grand Rapids, …Age 18+ - Tests patient's own tumor-fighting immune cells for several spread cancers
Tests tumor-fighting immune cells, grown in a lab, in adults with spread cancers.
Bethesda, United StatesAge 18 to 72 - Testing Trastuzumab Deruxtecan with Olaparib in HER2-expressing cancers
Tests a drug combination in adults with HER2-expressing cancers or platinum-resistant ovarian cancer.
Atlanta, United StatesAlso Boston, Coral Gables, Deerfield Beach, Doral, Jacksonville, Miami, Phoenix, Pittsburgh, …Age 18+ - Tests heated chemotherapy during surgery for abdominal lining tumors
Tests heated chemotherapy washed in the abdomen during surgery, in adults with abdominal tumors.
Bethesda, United StatesAge 18 to 120 - Tests IMNN-001 added to chemotherapy and bevacizumab in advanced ovarian cancer
Tests IMNN-001 with chemotherapy and bevacizumab in adults with newly diagnosed advanced ovarian cancer.
Baltimore, United StatesAlso Houston, New York, Oklahoma CityAge 18+ - Testing different amounts of M1774 and ZEN-3694 for recurring ovarian and endometrial cancer
Tests two drugs together in adults with returned ovarian or endometrial cancer.
Albuquerque, United StatesAlso Augusta, Chicago, Cleveland, Columbus, Detroit, Iowa City, Milwaukee, Oklahoma City, …Age 18+ - Pembrolizumab, bevacizumab and cyclophosphamide for high-grade ovarian cancer with remaining cancer cells
Tests pembrolizumab, bevacizumab and cyclophosphamide in leftover high-grade ovarian cancer.
Houston, United StatesAlso New YorkAge 18+ - Tests PLN-101095 with pembrolizumab in adults with advanced solid tumors
Tests PLN-101095, alone and with pembrolizumab, in adults with solid tumors that progressed on immunotherapy.
Atlanta, United StatesAlso Austin, East Brunswick, Edmonds, Fairfax, Fort Worth, Grand Rapids, Houston, Lake Success, …Age 18+ - Tests IMNN-001 with chemotherapy in newly diagnosed advanced ovarian cancer
Tests IMNN-001 added to chemotherapy in adults with advanced ovarian, tubal or peritoneal cancer.
Chattanooga, United StatesAlso Detroit, Milwaukee, Minneapolis, New Orleans, Orlando, Portland, Rochester, Sioux Falls, …Age 18+ - Tests Zoladex 10.8 mg ovarian suppression in premenopausal women with breast cancer
Tests Zoladex in premenopausal women with breast cancer.
Amsterdam, United StatesAlso Athens, Bethlehem, Billings, Cary, Chicago, Cleveland, Columbus, Des Moines, …Age 18 to 55 - Testing OPB-201 cell therapy for recurrent endometrial cancer and platinum-resistant ovarian cancer
Tests OPB-201, made from a person's own T cells, in recurrent endometrial or ovarian cancer.
Atlanta, United StatesAlso Detroit, Houston, Minneapolis, San FranciscoAge 18+ - First human test of TJ102 in advanced ovarian cancer and other solid tumors
Tests TJ102 in adults with advanced ovarian cancer or other solid tumors.
Fairfax, United StatesAlso Houston, Irving, Lake Success, Los Angeles, Nashville, Orlando, PhiladelphiaAge 18+ - Tests ETX-929, a KRAS inhibitor, in adults with advanced KRAS-altered solid tumors
Tests ETX-929, a KRAS inhibitor, in adults with advanced solid tumors carrying KRAS changes.
Fairfax, United StatesAge 18+ - Tests CTIM-76 in adults with recurring ovarian cancer and other solid tumors
Tests CTIM-76 in adults with advanced ovarian, testicular or endometrial cancer.
Beverly Hills, United StatesAlso Boston, Canton, Dallas, Denver, Durham, Hackensack, Little Rock, Nashville, …Age 18+ - Tests sacituzumab tirumotecan to keep recurrent ovarian cancer controlled
Tests a drug, with or without bevacizumab, in adults with recurrent ovarian cancer.
Albuquerque, United StatesAlso Anchorage, Atlanta, Augusta, Austin, Birmingham, Cincinnati, Columbus, Covington, …Age 18+ - Sac-TMT as follow-up treatment after chemotherapy for newly diagnosed advanced ovarian cancer
Tests sac-TMT, with or without bevacizumab, after chemotherapy in advanced ovarian cancer.
Albany, United StatesAlso Arlington Heights, Atlanta, Aurora, Birmingham, Cincinnati, Columbia, Covington, Durham, …Age 18+ - IDE034 for Advanced Solid Tumors Including Lung, Colorectal, Ovarian and Prostate Cancers
Tests IDE034 in adults with advanced solid tumors that carry B7-H3 and PTK7.
Austin, United StatesAlso Celebration, Denver, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, …Age 18+
Where treatment stands
Approved: 26
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 51
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 3
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 2
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.
Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 165 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for ovarian cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in United States, for you and your family.
Ovarian cancer organisations in United States
- National Cancer Institute – Cancer Information Service (CIS)
NCI's contact center: information specialists answer cancer questions from patients, families and the public by phone, chat and email.
- American Cancer Society
Nationwide US nonprofit helping people who face cancer: research, patient services, early detection, treatment information and education, with a cancer helpline on its site.
- Cactus Cancer Society
Young adult cancer resource and community: support programs for people diagnosed with cancer as young adults.
- Cancer Hope Network
Nonprofit providing free one-on-one support to cancer patients and families by matching them with trained volunteers who have had a similar experience.
- Cancer Nation
Survivor-led US cancer advocacy organization (formerly the National Coalition for Cancer Survivorship) working on quality cancer care and survivorship resources.
- FORCE – Facing Hereditary Cancer Empowered
Nonprofit for people and families facing hereditary cancer (e.g. BRCA): information on gene mutations, risk, and support.
- Foundation for Women's Cancer
Foundation bringing together advocates, patients, caregivers and care teams to eradicate gynecologic cancers.
- Georgia Ovarian Cancer Alliance (GOCA)
Georgia (GA) alliance for people with ovarian cancer and families, offering education, awareness, peer-to-peer support, Bag of Hope and resources.
- Imerman Angels
Nonprofit offering free one-on-one cancer support and personalized mentoring that connects cancer fighters, survivors and caregivers with someone who has been there.
- Michigan Ovarian Cancer Alliance (MIOCA)
Michigan group offering ovarian cancer survivors and families support groups, resources, awareness events, advocacy and research funding.
- National Ovarian Cancer Coalition (NOCC)
Information line, peer support groups, practical help (meal delivery, financial assistance), education.
- Ovarian Cancer Research Alliance (OCRA)
Patient support team, Woman to Woman peer mentors, Staying Connected support series, 1:1 counselling, genetic testing programme.
- SHARE Cancer Support
Free support for breast, ovarian, uterine and cervical cancer: toll-free national support line, Zoom groups incl. metastatic lobular and brain-metastases groups, ovarian cancer section.
- Triage Cancer
National nonprofit providing free education on legal and practical issues (insurance, employment, finances) for people with cancer and caregivers.
General support in United States
- 988 Suicide & Crisis Lifeline
US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.
- MedlinePlus
Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Treatments approved outside the EU
Medicines for ovarian cancer approved in the US or Japan that are not approved in the EU.
Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 8 uncertain matches are left out.
Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- CBD (cannabidiol) & Ovarian cancer
- Vitamin C (incl. high-dose) & Ovarian cancer
- Ivermectin & Ovarian cancer
- Fenbendazole & Ovarian cancer
About ovarian cancer
Sources: NHS, NCI PDQ, MedlinePlus, Cancer Research UK, NCI SEER
A cancer of the ovaries, the two small organs that store eggs and make female sex hormones. Signs include a swollen or bloated tummy, pain in the tummy or pelvis, feeling full quickly and needing to pee more often. The main treatments are surgery and chemotherapy; targeted medicines may be an option for some people whose cancer is advanced or has come back. It mostly affects women over 50, sometimes runs in families, and is often diagnosed late.
What is it?
The ovaries are two small organs that store eggs and make female sex hormones. The most common type of ovarian cancer starts in the cells that cover the ovary. Cancers of the fallopian tubes and of the lining inside the tummy (peritoneum) are very similar and are treated the same way, so they are grouped together. This is why you can still get it after your ovaries have been removed.
The risk grows with age. It mostly affects women over 50. It sometimes runs in families: faulty genes, such as the BRCA genes or those linked to Lynch syndrome, can raise the risk. Endometriosis, being overweight and smoking also raise the risk.
The first signs
Ovarian cancer may not cause early signs, and the signs are not always obvious. The main signs, often happening 12 or more times a month, are:
- a swollen tummy or feeling bloated;
- pain or tenderness in your tummy or between your hips (pelvis);
- no appetite, or feeling full quickly after eating;
- an urgent need to pee, or needing to pee more often.
Other signs are indigestion, constipation or diarrhoea, back pain, feeling tired all the time, losing weight without trying, and unusual bleeding from the vagina, for example after the menopause.
How doctors find out
Your family doctor usually arranges a blood test (for a marker called CA-125) and an ultrasound scan, either with a small probe inside the vagina or over the tummy. If the results point to ovarian cancer, you are sent to a gynaecological cancer specialist at a hospital.
Other tests can include a CT scan, a needle biopsy (a small sample of cells or fluid), or a laparoscopy: a camera on a thin tube put in through a small cut in the tummy. You may need more tests to find out the size of the cancer and how far it has spread. A specialist explains the results, and it helps to bring someone with you. A specialist nurse is your main contact during and after treatment.
Current treatment
Surgery and platinum-based chemotherapy
Will it get worse?
It depends on the type of cancer, how far it has spread, whether surgery can remove all of it, gene changes such as BRCA, and your general health. Ovarian cancer is often found late: in more than half of people it has already spread to distant parts of the body. Finding it early can make it easier to treat.
The cancer can come back, in the same place or elsewhere, so you have regular check-ups and tests after treatment. If it cannot be cured, treatment aims to hold it back, ease the symptoms and help you live longer, with help from a palliative care team.
Medicines: what helps, and what to watch for
Chemotherapy is medicine that kills cancer cells. It can be given before or after surgery, on its own, or if the cancer comes back. Chemotherapy can be given through a thin tube into a vein, or in some cases straight into the belly through a thin tube. Targeted medicines may be added: bevacizumab with chemotherapy, or PARP inhibitors (such as olaparib, niraparib or rucaparib), which stop cancer cells repairing their DNA. These medicines may be an option for some types of advanced ovarian cancer, or cancer that has come back. A gene test may help your team decide on your treatment plan. Hormone treatment is rarely used.
Good to know:
- Most people get some side effects of chemotherapy, but not all of them. Common ones are tiredness, feeling sick, a sore mouth, hair loss that is usually temporary, and numbness or tingling in the hands or feet;
- Treatment can affect periods and fertility in younger women. There may be ways to keep your fertility, and your specialist team will advise you about them;
Exercise and everyday care help too
Rest, but also some gentle physical activity, can help with tiredness. It can be hard to know whether your symptoms are due to the cancer and its treatment, or to the menopause.
Surgery, for most people
Most people have surgery to remove as much of the cancer as possible. If it has not spread beyond the ovaries, the surgeon may remove one or both ovaries and fallopian tubes, and the womb and cervix. If it has spread, the surgeon may also take out fatty tissue in the tummy, lymph nodes, and sometimes parts of the bowel or other organs.
Radiotherapy may be used to treat advanced cancer if other treatments are not right for you, or to help with symptoms such as bleeding, pain or discomfort.
Is there a cure?
It depends on the stage. Found early, it can be easier to treat. Advanced ovarian cancer may not be curable, and it can come back after treatment. Clinical trials are testing new treatments, such as vaccine therapy, and people at any stage can think about joining one.
Median survival
About 3 to 4 years with surgery and chemotherapy, for advanced cancer
Measured in: Advanced-stage disease, in three trials (GOG-0182, 4,312 patients; ICON7, 1,528 women; GOG-0218, 1,873 women)
The figures behind it
NCI PDQ (health professional), treatment of advanced-stage disease: median overall survival 44.1 months in the carboplatin-paclitaxel arm of GOG-0182 (4,312 patients), 44.6 months with standard chemotherapy in ICON7 (1,528 women) and 39.3 months in the control group of GOG-0218 (1,873 women). More than half of patients have distant spread at diagnosis (SEER).
Sources
Written in plain words by Frontlight from these pages:
- NHS: Ovarian cancer – Overview
- NHS: Ovarian cancer – Symptoms
- NHS: Ovarian cancer – Treatment
- MedlinePlus: Ovarian Cancer
- NHS: Ovarian cancer – Causes
- NHS: Ovarian cancer – Tests and next steps
- NCI PDQ: Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers Treatment (PDQ) – Patient Version
- NCI SEER: Cancer Stat Facts: Ovarian Cancer
- NHS: Chemotherapy – Side effects
- Cancer Research UK (charity): Coping and support when you have ovarian cancer
- NCI PDQ: Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers Treatment (PDQ) – Health Professional Version